Descending
|
07/15/2010 Michael J. Fox Foundation Commits up to $12 Million for Targeted Parkinson's Therapeutic Development in 2011
The Michael J. Fox Foundation has committed up to $12 million in 2011 funding for prioritized research toward transformative treatments and a cure for Parkinson’s disease.
07/13/2010 Mrs. Lily Safra's Lead Gift of $2.5 Million to Support Landmark Study to Find Biomarkers of Parkinson's Disease
Philanthropist Lily Safra's gift will support the Parkinson’s Progression Markers Initiative (PPMI). Mrs. Safra’s commitment will help galvanize the search for a biomarker of Parkinson’s disease progression.
07/08/2010 The Michael J. Fox Foundation Awards $1.1 Million for Validation of Parkinson's Disease Therapeutic Targets
The Foundation’s Target Validation initiative, one of MJFF’s Edmond J. Safra Core Programs for PD Research, provides intellectual and financial resources to validation studies, helping to advance potential PD drug targets toward clinical trials and Parkinson’s patients.
07/06/2010 In New York City this July? Visit our interactive Team Fox display window at 10 Rockefeller Plaza!
The Michael J. Fox Foundation for Parkinson's Research thanks EHE International for helping raise awareness through an interactive display window in the heart of Rockefeller Center.
07/06/2010 Michael J. Fox Foundation Announces $1.1 Million to Advance Leading Biomarker Candidates for Parkinson's Disease
The discovery and validation of biomarkers is of critical importance to increasing the speed and efficiency of PD therapeutic development.
07/01/2010 Michael J. Fox Foundation Awards $3 Million to Push Eight Industry Parkinson's Drug Development Projects toward Commercialization
Funded investigations aim to push forward approaches that could slow or stop progression of the disease, alleviate symptoms or refine existing therapies.
06/29/2010 MJFF Announces New Web Features on PD Online Research
PD Online Research is a Web-based community of Parkinson's scientists, clinicians, health care providers, drug developers and funders who exchange ideas and information online in an effort to speed research progress.
06/22/2010 MJFF Awards $4.6 Million to Help Advance Neurotrophic Factors Research
The awards support two promising studies of neurotrophic factor therapies to help speed this avenue of research toward better treatments for people living with PD.
04/30/2010 Denny's Restaurants Join the Michael J. Fox Foundation for Pancakes for Parkinson's
Denny’s events kick off in New York to support Parkinson’s disease research
04/23/2010 MJFF Awards More Than $3 Million to Advance Parkinson's Disease Research
The funded projects complement the Foundation’s annually occurring Pipeline Programs and Critical Challenges in Parkinson’s Disease initiatives, which aim to accelerate PD therapeutic development.
04/21/2010 MJFF Launches Parkinson's Progression Markers Initiative (PPMI)
The groundbreaking, $40 million, five-year observational clinical study seeks to identify biomarkers of Parkinson’s disease.
03/23/2010 MJFF Offers High-Quality LRRK2 Antibodies for PD Therapeutic Development
MJFF is making antibodies available to Parkinson's researchers around the world at no cost.
03/05/2010 Michael J. Fox Receives Honorary Doctorate from Karolinska Institute
Karolinska awards honorary doctorates to people who have not earned a PhD through formal academic achievements, but who have benefited research through other means.
03/02/2010 MJFF Commits up to $5.75 Million in Funding for 2010 Critical Challenges in Parkinson's Disease
Two Challenges aim to streamline efforts focused on genetic targets alpha-synuclein and LRRK2. The third will drive collaborations that maximize the resources of the Brain & Body Donation Program at the Arizona Parkinson’s Disease Consortium.
02/18/2010 MJFF Awards $1.1 Million for Clinical Trial of Transdermal Nicotine as Disease-modifying Treatment for Parkinson's
Researchers will evaluate the disease-modifying potential of transdermal nicotine using standard skin patches of the type used by millions of smokers as a quitting aid.
02/17/2010 MJFF Awards $3.5 Million to Advance LRRK2 Therapeutic Development Efforts
Using a multipronged approach that includes collaboration between the research teams, the funded projects will help advance understanding of the LRRK2 gene.
02/09/2010 MJFF Awards $1 Million to Drive Critical New Research Tools and Technologies in Parkinson's Drug Development
Strategic investment in new research technologies and tools is critical to attaining transformative new treatments that will make a tangible impact on patients’ lives.
02/04/2010 MJFF Awards $2.8 Million to Drive Development of Parkinson's Disease Biomarker Pipeline
The discovery of PD biomarkers, physiological characteristics that can be objectively measured and evaluated by researchers, are critical to PD drug development.
01/19/2010 MJFF Awards $2.1 Million to Drive Six Industry Teams' Pre-clinical Development of Neuroprotective Parkinson's Therapies
Three teams will focus on inflammation and oxidative stress, two will target alpha-synuclein, and one will investigate HDACs, a family of enzymes shown to enhance expression of potential protective factors in preclinical PD models.
